Share ownership Johnson & Johnson

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 19:38:25 19/05/2026 BST			5-day change	1st Jan Change
229.02 ^USD	+0.05%		+2.35%	+10.91%

05:35pm	Johnson & Johnson Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 11:30 AM
09:29am	Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case	MT

Share class: Johnson & Johnson

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,120,474,971	2,405,878,433 ( 77.1 %)	713,258,000 ( 22.86 %)	77.1 %

Major shareholders: Johnson & Johnson

Name	Equities	%	Valuation
Vanguard Capital Management LLC 7.504 %	180,631,228	7.504 %	41 518 M $
BlackRock Advisors LLC 6.628 %	159,554,488	6.628 %	36 674 M $
Vanguard Capital Management LLC 6.506 %	156,605,370	6.506 %	35 996 M $
STATE STREET CORPORATION 5.545 %	133,476,288	5.545 %	30 680 M $
Vanguard Portfolio Management LLC 2.639 %	63,514,436	2.639 %	14 599 M $
JPMorgan Investment Management, Inc. 2.621 %	63,096,344	2.621 %	14 503 M $
Geode Capital Management LLC 2.458 %	59,164,862	2.458 %	13 599 M $
BlackRock Life Ltd. 1.996 %	48,051,430	1.996 %	11 045 M $
Eaton Vance Management 1.858 %	44,721,167	1.858 %	10 279 M $
Norges Bank (13F) 1.39 %	33,459,884	1.39 %	7 691 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Itaú Unibanco Asset Management Ltda. 0.000462 %	167,007	0.000462 %	3 M $

Breakdown by shareholder type

Institutional	66.84%
Other	7.98%
State Street Corp.	5.54%
Schweizerische Nationalbank	0.29%
Sumitomo Mitsui Trust Group, Inc.	0.24%
Governments	0.16%
Manulife Financial Corp.	0.15%
Swedbank AB	0.12%
SEI Investments Co.	0.09%
Danske Bank A/S	0.09%
Fifth Third Bancorp	0.08%
Individuals	0.04%
Regions Financial Corp.	0.03%
The Bank of Nova Scotia	0.03%
Rathbones Group Plc	0.03%
First Financial Bankshares, Inc.	0.03%
Markel Group, Inc.	0.03%
Peapack-Gladstone Financial Corp.	0.02%
ING Groep NV	0.02%
Zurich Insurance Group AG	0.02%
Pinnacle Financial Partners, Inc.	0.02%
Commerzbank AG	0.02%
Silvercrest Asset Management Group, Inc.	0.02%
Cincinnati Financial Corp.	0.01%
Associated Banc-Corp	0.01%
Clal Insurance Enterprises Holdings Ltd.	0.01%
First Horizon Corp. (Tennessee)	0.01%
Hancock Whitney Corp.	0.01%
The Allstate Corp.	0.01%
Old Republic International Corp.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Unknown	18.02%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	62.76%
United Kingdom	7.98%
Canada	3.34%
Norway	1.48%
Australia	0.78%
Japan	0.76%
France	0.75%
Sweden	0.68%
Germany	0.67%
Switzerland	0.64%
Denmark	0.41%
Hong Kong	0.37%
South Korea	0.3%
Ireland	0.17%
Netherlands	0.16%
Italy	0.12%
Luxembourg	0.1%
Belgium	0.09%
Finland	0.07%
New Zealand	0.05%
Individuals	0.04%
Czech Republic	0.03%
Liechtenstein	0.03%
Portugal	0.03%
Austria	0.03%
Singapore	0.03%
Spain	0.03%
South Africa	0.02%
Slovenia	0.01%
China	0.01%
Saudi Arabia	0.01%
Israel	0.01%
Brazil	0.01%
Malaysia	0.01%

Based on 1000 largest holdings

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.

Employees

138,200

Sector

Pharmaceuticals

Calendar

05-26 - Ex-dividend date - 1.34 USD

More about the company